Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

Area of Science:

• Molecular biology
• Virology
• Oncology

Background:

• p53 tumor suppressor protein is frequently mutated in human cancers.
• Viral proteins from papillomavirus, adenovirus, and simian virus 40 interact with p53.
• Epstein-Barr virus (EBV) infection is linked to B-cell lymphomas and nasopharyngeal carcinoma.

Purpose of the Study:

• To investigate the interaction between EBV immediate-early protein BZLF1 (Z) and p53.
• To determine the functional consequences of this interaction on viral latency and p53 activity.

Main Methods:

• In vitro and in vivo interaction assays.
• Co-immunoprecipitation to confirm binding.
• Functional assays measuring viral latency switch and p53 transactivation.

Main Results:

• EBV protein Z directly interacts with p53.
• The interaction involves Z's coiled-coil dimerization domain and p53's carboxy-terminal portion.
• Overexpression of p53 inhibits Z-mediated disruption of viral latency.
• Z inhibits p53-dependent transactivation in lymphoid cells.

Conclusions:

• The direct interaction between EBV Z protein and p53 plays a role in regulating the switch from latent to lytic viral infection.
• This interaction may contribute to the development of EBV-associated malignancies.
• Understanding this interaction could lead to novel therapeutic approaches for EBV-related cancers.